ESC Professional Premium Access

Pathophysiological and therapeutic implications of urocortin-2 in heart failure with preserved ejection fraction

Congress Presentation

About the speaker

Miss Ines Vasconcelos

Faculty of Medicine University of Porto, Porto (Portugal)
1 presentation
0 follower

6 more presentations in this session

The histone methyltransferase SETD2 drives cardiometabolic heart failure with preserved ejection fraction

Speaker: Mr S. Ambrosini (Schlieren, CH)

Thumbnail

The role of endothelial adipose triglyceride lipase (ecATGL) in heart failure with preserved ejection fraction (HFpEF)

Speaker: Doctor J. Schwanbeck (Berlin, DE)

Thumbnail

Alterations in the gut microbiota composition in the obesity phenotype of heart failure with preserved ejection fraction

Speaker: Mr Y. Rokach (Jerusalem, IL)

Thumbnail

Induction of periodontitis and oral microbiome dysbiosis in a mouse model with heart failure with preserved ejection fraction results in worsening hypertension and diastolic dysfunction

Speaker: Ms S. Da'Na (Jerusalem, IL)

Thumbnail

Enhancing NO pathway improves diastolic function in a hamster model of heart failure with preserved ejection fraction associated with nonalcoholic steatohepatitis

Speaker: Doctor C. Dubroca (Escalquens, FR) Doctor F. Briand (FR)

Thumbnail

Access the full session

Pathomechanisms of heart failure with preserved ejection fraction

Speakers: Miss I. Vasconcelos, Mr S. Ambrosini, Doctor J. Schwanbeck, Mr Y. Rokach, Ms S. Da'Na...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk